Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-001385
Filing Date
2017-01-31
Accepted
2017-01-31 16:53:38
Documents
1
Period of Report
2017-01-27

Document Format Files

Seq Description Document Type Size
1 KMPH-FORM4_20170131_MICKLET rdgdoc.html 4  
1 KMPH-FORM4_20170131_MICKLET rdgdoc.xml 4 6964
  Complete submission text file 0001437749-17-001385.txt   8408
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2656 CROSSPARK ROAD SUITE 100 CORALVILLE IA 52241
Business Address
Mickle Travis C (Reporting) CIK: 0001638365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 17561768